C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1992
11/03/1992	CA1309679C Serum free media for the growth of insect cells and expression of products thereby
11/03/1992	CA1309677C Monoclonal wee-1 b-cell line
11/03/1992	CA1309676C Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor viii:c
11/03/1992	CA1309671C Monoclonal antibodies to cyclosporins
11/03/1992	CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens
11/03/1992	CA1309588C Method for cutting plant material
11/02/1992	CA2067477A1 Plant promoter sequences
10/1992
10/29/1992	WO1992018639A1 Novel retro-alpha-retinol derivatives and uses of retro-alpha-retinol
10/29/1992	WO1992018634A1 Plant promoter involved in controlling lipid biosynthesis in seeds
10/29/1992	WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992	WO1992018617A1 In vitro leaf petiole multiplication of pelargoniums
10/29/1992	WO1992018615A1 System and process for supporting hematopoietic cells
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018149A1 Assay systems for neurotrophin activity
10/29/1992	WO1992018137A1 Method for inducing bone formation using an extract of human osteosarcoma cell line saos-2
10/29/1992	WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992	WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method
10/29/1992	WO1991018992A3 Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen
10/29/1992	CA2109100A1 Assay systems for neurotrophin activity
10/29/1992	CA2107897A1 System and process for supporting hematopoietic cells
10/28/1992	EP0511011A1 Novel antibodies and methods for their use
10/28/1992	EP0510773A1 Canine coronavirus subunit vaccine
10/28/1992	EP0510393A1 Biocompatible, low protein adsorption affinity matrix
10/28/1992	EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992	EP0510075A1 Human receptor of tsh. sequence coding for such receptor
10/28/1992	EP0243485B1 Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin
10/28/1992	CN1065729A Monoclonal antibodies
10/28/1992	CN1065683A Production of plants resistant to attacks by sclerotinia sclerotiorum by introduction of gene encoding oxalate oxidase
10/28/1992	CN1065681A Cell ablation using trans-splicing ribozymes
10/28/1992	CA2067039A1 Neurotrophic peptide derivatives
10/27/1992	US5158886 Monoclonal antibodies specific for free N-acetylfuraminic acid and beta-glycosides and beta-glycoconjugates thereof
10/27/1992	US5158885 Mouse monoclonal antibodies raised to the t-cell line hsb-2 and t-cell chronic lymphocytic leukemia (t-cll) cells react with normal human t and b lymphocytes and monocytes
10/27/1992	US5158881 Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
10/27/1992	US5158874 Determining metastic potential of tumor cells and isolating metastic tumor cells
10/27/1992	CA1309367C Efficient method for regenerating cotton from cultured cells
10/21/1992	EP0509826A1 Subunit of the human interleukin 3 receptor
10/21/1992	EP0509008A1 Biomass for the production of viruses/virus antigens.
10/21/1992	EP0481000A4 Receptors for fibroblast growth factors
10/21/1992	EP0457856A4 Isolation growth and differentiation of human muscle cells
10/20/1992	WO1992018628A1 Subunit of the human interleukin-3 receptor
10/20/1992	WO1992018618A1 Modified plant viruses as vectors
10/20/1992	US5156977 Monoclonal antibodies against atrial, natriuretic peptides of humans, hybridomas & methods of use
10/20/1992	US5156969 Treating vascular disorders
10/20/1992	US5156964 Methods for adapting cells for increased product production through exposure to ammonia
10/20/1992	US5156957 Transformed mammalian cell containing an expression vector which is capable of producing a heterodimeric human fertility hormone coded by a distinct RNA
10/20/1992	US5156844 For controlled delivery of a neurotransmitter to the brain
10/20/1992	CA2102224A1 Human interleukin-3-receptor component
10/20/1992	CA1309041C Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i
10/20/1992	CA1309039C Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
10/17/1992	WO1992018643A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/17/1992	CA2108565A1 The use of pasteurella haemolytica glycoprotease in a process for recovering cells rich in o-glycosylated surface portions
10/15/1992	WO1992017779A1 Method of identifying and modulating the activity of label retaining cells for diagnostic and therapeutic purposes
10/15/1992	WO1992017604A1 Anti-eda monoclonal antibody
10/15/1992	WO1992017602A1 Parathyroid hormone receptor and dna encoding same
10/15/1992	WO1992017567A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	WO1992017566A2 Methods for selection of recombinant host cells expressing high levels of a desired protein
10/15/1992	WO1992017505A1 Monoclonal antibodies to stem cell factor receptors
10/15/1992	WO1992017500A1 Novel megakaryocyte amplifying factor and production thereof
10/15/1992	WO1992017498A1 Product and method for improving keratinocyte adhesion to the dermis
10/15/1992	WO1992017497A1 Human pf4a receptors and their use
10/15/1992	WO1992017486A1 Totipotent hematopoietic stem cell receptors and their ligands
10/15/1992	WO1992017211A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences
10/15/1992	WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992	WO1992017193A1 Medicament containing an agent inhibiting in vivo pathological apoptosis and applications thereof
10/15/1992	CA2407304A1 Human pf4a receptors and their use
10/15/1992	CA2116362A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
10/15/1992	CA2107789A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences
10/15/1992	CA2106862A1 Method of indentifying and modulating the activity of label retaining cells for diagnostic and therapeutic purposes
10/14/1992	EP0508909A1 Chimeric gene for the transformation of plants
10/14/1992	EP0508809A1 Proteinaceous lipid-containing particles
10/14/1992	EP0508496A1 Methods of reconstituting lyophilized cells including reconstituting media
10/14/1992	EP0508472A2 Method of producing hybridomas
10/14/1992	EP0508282A2 Anti-idiotypic monoclonal antibodies
10/14/1992	EP0508221A1 Somatostatin receptor
10/14/1992	EP0507948A1 Monoclonal antibody, hybridomas, their production and use
10/14/1992	EP0507934A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics
10/14/1992	EP0507849A1 Cool storage of cultured epithelial sheets.
10/14/1992	EP0507839A1 Method of separating haemopoietic progenitor cells.
10/14/1992	EP0507772A1 Non-melanocytic, eucaryotic cell constitutively expressing biologically active human tyrosinase and use thereof
10/14/1992	EP0476093A4 Production of improved rapeseed exhibiting a reduced saturated fatty acid content
10/14/1992	CN1065293A Entomopoxvirus expression system
10/13/1992	US5155218 Dna encoding human 5-ht1d receptors
10/13/1992	US5155212 Substituted phencyclidine compound linked to polyamino acid
10/13/1992	US5155036 Serum-free medium containing retinoic acid useful for cultivating human/human hybridomas
10/13/1992	US5155035 Method for culturing mammalian cells in a perfused bioreactor
10/13/1992	US5155034 Three-dimensional cell to tissue assembly process
10/13/1992	US5154921 Removing cells from animal, contacting with polypeptide growth factor, GRO
10/13/1992	CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
10/13/1992	CA1308676C Anti-human igg (immunoglobulin g) monoclonal antibody and process for preparing the same
10/11/1992	WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992	CA2107879A1 Proteinaceous lipid-containing particles
10/11/1992	CA2065681A1 Method of producing hybridomas
10/09/1992	WO1992017591A1 A plant chitinase gene and use thereof
10/09/1992	CA2106309A1 Plant chitinase gene and use thereof
10/09/1992	CA2048696A1 Plant chitinase gene and use thereof
10/09/1992	CA2048477A1 Plant chitinase gene and use thereof
10/07/1992	EP0507698A1 Histone promotors
10/07/1992	EP0506890A1 Recombinant thyrotropin receptor
10/07/1992	EP0506821A1 Hybrid protein c
10/07/1992	EP0506766A1 Hepatocellular carcinoma oncogene

1 ... 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 ... 1827